← Back to Search

Laboratory based assessments for Bone Blood Flow Regulation

N/A
Recruiting
Led By J. A Taylor, PhD
Research Sponsored by Spaulding Rehabilitation Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Study Summary

This trial will study how blood flow affects bone in people with and without spinal cord injuries.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Tibial blood perfusion

Trial Design

1Treatment groups
Experimental Treatment
Group I: Laboratory based assessmentsExperimental Treatment1 Intervention
The current study has no arms; it is a cross-sectional assessment where all participants will undergo the same procedures.

Find a Location

Who is running the clinical trial?

Spaulding Rehabilitation HospitalLead Sponsor
134 Previous Clinical Trials
10,885 Total Patients Enrolled
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
483 Previous Clinical Trials
1,086,810 Total Patients Enrolled
J. A Taylor, PhDPrincipal InvestigatorHarvard Medical School/Spaulding Rehabilitation Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial accept applicants who are beyond thirty years of age?

"The essential criteria for this clinical trial necessitates that participants be between the ages of 18 and 40."

Answered by AI

Who is the ideal candidate for this experimental procedure?

"This clinical trial is seeking 130 individuals with bone blood flow regulation who are between the ages of 18 and 40. The primary requirement for participation is that patients must be healthy males or females."

Answered by AI

To what extent is this research endeavor being implemented with patients?

"That is correct. According to clinicaltrials.gov, this medical trial - which was initially posted on November 26th 2019- is presently enrolling 130 participants from a single location. The data has been recently updated as of February 21st 2023."

Answered by AI

Are there still openings to be part of this clinical exploration?

"Affirmative. According to clinicaltrials.gov, this medical research has been actively recruiting since November 26th 2019 and was last updated on February 21st 2023. The study requires 130 participants from 1 location."

Answered by AI
~24 spots leftby Apr 2025